Overview

rs735482 is a genetic variant on gene ERCC1.

This variant is located on chromosome 19. The variations at position 45408744 are the genetic letters A/A, C/C, A/C

Since humans have each twice (one from each parent), these letter-variations occur on both chromosomes. People can have the same or different letters on both chromosomes. Every person's individual variation combination is referred to as genotype. For variant rs735482 there are 3 currently known genotypes : A/A, C/C or A/C

Short Overview

Variant Location

rs735482 is located on gene ERCC1 in chromsome 19. Use the genome browser to explore the location of rs735482 and its genetic neighbourhood.

Conditions & Traits

rs735482 affects the following conditions and traits:

There are currently 0 conditions and 0 traits associated with rs735482.

Pathogenicity

rs735482 affects the following conditions:

There are currently 0 conditions associated with rs735482.

Pharmacogenetics

rs735482 affects the following drugs:

Genome Browser

This interactive browser visualizes what no human can see with the naked eye - our DNA. From a down to a specific position on a . The position you are looking at here is the exact location of variant rs on gene ERCC1. Explore more variants and their effects on the body by browsing left and right along the DNA strand.

Loading Genome Browser...

Did you know genetic variants affect drugs?

Mutations are changes in genes and genetic variations are differences in the DNA among people. Variants are tiny changes in just one piece of the DNA while haplotypes are groups of these changes that usually come together.

Dr. Wallerstorfer Dr. Wallerstorfer

Conditions & Traits of rs735482

Current research shows 0 conditions and 0 traits.

Conditions

0

Pharmacogenetics

The genetic variant rs735482 impacts how certain medications work in the body. This difference may cause some of us to require different dosage amounts to achieve the desired effects, while others might experience more apparent side-effects. As a result, healthcare providers may need to adjust prescriptions for those individuals with rs735482. Ultimately, understanding our genetic makeup helps improve the overall effectiveness and usability of medications. Tailoring treatments based on genetics ensures a safer, more personalized healthcare experience.

Genotype
Level of evidence
Impacts
Summary
AA

Breakdown

Drug Effect

Side Effects

Dosage

Individuals with the genotype A/A have decreased Drug Effect to THALIDOMIDE.

more info

AC

Breakdown

Drug Effect

Side Effects

Dosage

Individuals with the genotype A/C have increased Drug Effect to THALIDOMIDE.

more info

CC

Breakdown

Drug Effect

Side Effects

Dosage

Individuals with the genotype C/C have increased Drug Effect to THALIDOMIDE.

more info

Legend:

Increased

Decreased

No known effect

Genotype
AA
Impacts

Breakdown

Drug Effect

Side Effects

Dosage

Summary

Individuals with the genotype A/A have decreased Drug Effect to THALIDOMIDE.

Level of evidence

More info

Genotype
AC
Impacts

Breakdown

Drug Effect

Side Effects

Dosage

Summary

Individuals with the genotype A/C have increased Drug Effect to THALIDOMIDE.

Level of evidence

More info

Genotype
CC
Impacts

Breakdown

Drug Effect

Side Effects

Dosage

Summary

Individuals with the genotype C/C have increased Drug Effect to THALIDOMIDE.

Level of evidence

More info

Legend:

Increased

Decreased

No known effect

Drugs related to rs735482

All drugs that are linked to rs735482 are listed here.

Studies and Sources

All of the resources below examine variant rs735482

Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies (8/21/17)

Junjun Wang, Qingyun Liu, Shuai Yuan, Weijia Xie, Yuan Liu, Ying Xiang, Na Wu, Long Wu, Xiangyu Ma, Tongjian Cai, Yao Zhang, Zhifu Sun, Yafei Li

PMC: 5567126
The polymorphisms of miRNA‐binding site in MLH3 and ERCC1 were linked to the risk of colorectal cancer in a case–control study (3/8/18)

Qianye Zhang, Xiao Zheng, Xiaoxia Li, Deyu Sun, Ping Xue, Guopei Zhang, Mingyang Xiao, Yuan Cai, Cuihong Jin, Jinghua Yang, Shengwen Wu, Xiaobo Lu

PMC: 5911615
Rs3212986 polymorphism, a possible biomarker to predict smoking‐related lung cancer, alters DNA repair capacity via regulating ERCC1 expression (11/19/18)

Tao Yu, Ping Xue, Su Cui, Liang Zhang, Guopei Zhang, Mingyang Xiao, Xiao Zheng, Qianye Zhang, Yuan Cai, Cuihong Jin, Jinghua Yang, Shengwen Wu, Xiaobo Lu

PMC: 6308093
DISCLAIMER: The materials present on Genopedia.com, such as text, images, graphics, among other items (“Content”), are shared purely for informational reasons. This content should not replace professional health advice, medical diagnoses, or treatment procedures. Whenever you have health concerns or questions, it’s always recommended to engage with your doctor or another appropriate healthcare provider. If you read something on the Genopedia.com site, do not neglect professional medical counsel or delay in obtaining it. In case you believe you’re dealing with a medical crisis, get in touch with your medical professional or call emergency without delay. Genopedia.com doesn’t advocate for any particular medical tests, healthcare providers, products, methods, beliefs, or other data that could be discussed on the site. Please also note that the content, originally written in English and in part created with the help of artificial intelligence, is provided without any warranty, and any reliance on information offered by Genopedia.com, its staff, contributors invited by Genopedia.com, or site users is entirely at your own risk.
Genopedia © 2026 all rights reserved